中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

2018 No. 2

Display Method:
Editorial
A risk assessment of disease progression after virus elimination with chronic hepatitis C
Wang Qin, Luo BiFen, Wei Lai
2018, 34(2): 227-228. DOI: 10.3969/j.issn.1001-5256.2018.02.001
Abstract:
With reference to various clinical studies on interferon-α and pegylated interferon-α around the world, patients with chronic hepatitis C who receive antiviral therapy and achieve the elimination of hepatitis C virus may have significant relief or even reversion of liver fibrosis, as well as reducti...
Discussions by experts
Drug-drug interaction of direct-acting antivirals in treatment of chronic hepatitis C
Wang MengLan, Tang Hong
2018, 34(2): 229-232. DOI: 10.3969/j.issn.1001-5256.2018.02.002
Abstract:

With the successful application of direct-acting antivirals (DAAs) in the treatment of hepatitis C, clinical management of drug-drug interaction (DDI) has become a hot topic in this field.Most DAAs develop DDI with other drugs administered at the same time via cytochrome P450 or transporters in the ...

Selection and evaluation of treatment regimens with direct-acting antiviral agents for patients with chronic hepatitis C in the real world in China
An ZiYing, Ding Yang, Dou XiaoGuang
2018, 34(2): 233-237. DOI: 10.3969/j.issn.1001-5256.2018.02.003
Abstract:

Chronic hepatitis C (CHC) is a chronic and progressive disease prevalent in the whole world and greatly threatens human health.The launch of direct-acting antiviral agents (DAAs) brings a revolutionary change in the treatment of CHC.In recent years, several DAAs have been marketed in foreign countri...

Features and management of patients with hepatitis C virus/hepatitis B virus dual infection associated with the application of direct-acting antiviral agents
Yu YueCheng, Fan Ye, Li Ping
2018, 34(2): 238-241. DOI: 10.3969/j.issn.1001-5256.2018.02.004
Abstract:

Dual infection with hepatitis C virus (HCV) and hepatitis B virus (HBV) has significantly different clinical, immunological, and virological features from single infection with HCV or HBV, which brings various challenges to clinical diagnosis/treatment and management.Direct-acting antiviral agents u...

Management and treatment of special populations with hepatitis C virus infection in the era of direct-acting antiviral agents
Li JunLi, Shang Jia, Ning HuiBin
2018, 34(2): 242-245. DOI: 10.3969/j.issn.1001-5256.2018.02.005
Abstract:

Chronic Hepatitis C is a global epidemic, and people with different sexes, ages, races, and nationalities are susceptible to hepatitis C virus (HCV) infection.This article elaborates on the management method and individualized treatment regimens for special populations, including children with hepat...

Focus on the treatment of chronic hepatitis C in children
Nan YueMin, Li DongDong, Kong LingBo
2018, 34(2): 246-250. DOI: 10.3969/j.issn.1001-5256.2018.02.006
Abstract:

Chronic hepatitis C in children has an insidious onset and has few available treatment options.Pegylated interferon alpha (Peg-IFNα) combined with ribavirin (RBV) , known as the PR regimen for short, used to be the standard regimen; however, treatment response is often affected by various factors in...

Selection of direct-acting antiviral agents in treatment of chronic hepatitis C patients with renal dysfunction
Chen JianHong, Xu XiaoYuan
2018, 34(2): 251-254. DOI: 10.3969/j.issn.1001-5256.2018.02.007
Abstract:

The incidence of hepatitis C virus infection is commonly seen in patients with renal dysfunction (RD) , especially those with end-stage renal disease on hemodialysis (HD) , among whom the incidence and mortality of liver diseases increase.The development of direct-acting antiviral agents has revolut...

Therapeutic guidelines
Guidelines for clinical application of two-dimensional shear wave elastography in assessment of liver fibrosis in chronic hepatitis B
Panel of Elastography Assessment of Liver Fibrosis, Study Group of Interventional Ultrasound, Society of Ultrasound in Medicine of Chinese Medical Association
2018, 34(2): 255-261. DOI: 10.3969/j.issn.1001-5256.2018.02.008
Abstract:
An excerpt of BSG guidelines on the management of abnormal liver blood tests (2017)
Xue Han, Li Jin, Sheng EXiang, Li YiRong
2018, 34(2): 262-267. DOI: 10.3969/j.issn.1001-5256.2018.02.009
Abstract:
Original articles_Viral hepatitis
Efficacy and safety of interferon-α given additionally or sequentially after long-term entecavir therapy in treatment of chronic hepatitis B
Gao ShengLi, Zhao Gang, Xu MiQin, Shen Yan, Yu Jing, Ye Yang, He LiHua, Jin WenJuan, Sun GuiYing, Niu ZhiLin
2018, 34(2): 268-271. DOI: 10.3969/j.issn.1001-5256.2018.02.010
Abstract:

Objective To investigate the efficacy and safety of interferon-α (IFN-α) given additionally or sequentially after effective inhibition of HBV DNA by long-term entecavir (ETV) therapy versus ETV alone in the treatment of chronic hepatitis B (CHB) .Methods A total of 27 CHB patients with negative HBV ...

Clinical effect of tenofovir disoproxil fumarate versus entecavir in treatment of treatment-naïve patients with chronic HBV infection
Zhang JiaWei, Geng JiaBao, Lu Feng, Dong Yu
2018, 34(2): 272-275. DOI: 10.3969/j.issn.1001-5256.2018.02.011
Abstract:

Objective To investigate the antiviral effect of tenofovir disoproxil fumarate (TDF) versus entecavir (ETV) in the treatment of treatment-nave patients with chronic HBV infection.Methods A total of 420 treatment-nave patients with chronic HBV infection or liver cirrhosis who received antiviral the...

Expression of Toll-like receptors 2 and 3 in liver tissue and its clinical significance in patients with chronic hepatitis B
Yang JingYi, Cheng ShuQuan, Cao YaZhao, Huang ChengJun, Jiang FuMing
2018, 34(2): 276-280. DOI: 10.3969/j.issn.1001-5256.2018.02.012
Abstract:

Objective To investigate the correlation of the expression of Toll-like receptor 2 (TLR2) and Toll-like receptor 3 (TLR3) in live tissue with the grade of liver inflammation and degree of liver fibrosis and related clinical significance in patients with chronic hepatitis B (CHB) .Methods A total of ...

Pathological features of liver tissue in autoantibody-positive chronic hepatitis C patients after plasmaphoresis
Wu HuiLi, Zheng SuJun, Wang TaiLing, Yan HuiPing, Ren Feng, Li JunFeng, Chen Yu, Liu Mei, Liu Shuang, Duan ZhongPing
2018, 34(2): 281-286. DOI: 10.3969/j.issn.1001-5256.2018.02.013
Abstract:

Objective To investigate the detection rate and features of autoantibodies in chronic hepatitis C (CHC) patients after plasmaphoresis, as well as the liver pathological features of autoantibody-positive CHC patients.Methods A total of 120 patients who were infected with hepatitis C virus after plasm...

Influence of the Notch signaling pathway on CD8+T lymphocyte function in patients with chronic hepatitis C
Li Yu, Zhang Hong, Li Zhu, Liu QingE, Wang Lu, Zhang Dan, Cao NingJia, Su Li
2018, 34(2): 287-291. DOI: 10.3969/j.issn.1001-5256.2018.02.014
Abstract:

Objective To investigate the influence of the Notch signaling pathway on CD8+T lymphocyte function in patients with chronic hepatitis C (CHC) and the role of the Notch signaling pathway in the pathogenesis of CHC.Methods A total of 38 treatment-na6 ve CHC patients who visited Shaanxi Provincial Peop...

Original articles_Liver neoplasms
Value of albumin-bilirubin score combined with aspartate aminotransferase-to-platelet ratio index in predicting the development of posthepatectomy liver failure in patients with HBV-related hepatocellular carcinoma
Mai RongYun, Ye JiaZhou, Wang YanYan, Bai Tao, Chen Jie, Huang Shan, Wu GuoBin, Wu FeiXiang, Zhao YinNong, Li LeQun
2018, 34(2): 292-297. DOI: 10.3969/j.issn.1001-5256.2018.02.015
Abstract:

Objective To investigate the value of albumin-bilirubin (ALBI) score combined with aspartate aminotransferase-to-platelet ratio index (APRI) in predicting the development of posthepatectomy liver failure (PHLF) in patients with HBV-related hepatocellular carcinoma (HCC) .Methods A retrospective anal...

Association of serum interleukin-17 level with early recurrence and prognosis after radical surgery in hepatocellular carcinoma patients with different levels of alpha-fetoprotein
Deng WeiWei, Zhu WenMing, Yi Chao, Feng YangChun, Huang YanChun
2018, 34(2): 298-302. DOI: 10.3969/j.issn.1001-5256.2018.02.016
Abstract:

Objective To investigate the expression of interleukin-17 (IL-17) in hepatitis B virus (HBV) -related hepatocellular carcinoma (HCC) with different levels of alpha-fetoprotein (AFP) , as well as its association with recurrence and prognosis after radical treatment for HCC.Methods A total of 167 pati...

Application of enhanced recovery after surgery versus traditional rehabilitation program in hepatectomy: a Meta-analysis
Li Le, Chen JinMing, Liu ZhongHua, Li Qiang, Shi Ying
2018, 34(2): 303-308. DOI: 10.3969/j.issn.1001-5256.2018.02.017
Abstract:

Objective To investigate the effect of enhanced recovery after surgery (ERAS) versus traditional rehabilitation program in patients undergoing hepatectomy.Methods Pub Med, EBSCO, MEDLINE, and Cochrane Library were searched for the articles on the effect of ERAS versus traditional rehabilitation prog...

Expression of the long non-coding RNA XLOC-007123 in hepatitis B-related hepatocellular carcinoma and its clinical significance
Lei GuangLin, Wang Quan, Cheng SiJie, Lai ChengCai, Wang KeYu, Yan Jin, Yang PengHui, Zhang ShaoGeng
2018, 34(2): 309-313. DOI: 10.3969/j.issn.1001-5256.2018.02.018
Abstract:

Objective To investigate the expression of the long non-coding RNA (lncRNA) XLOC-007123 in cancer and adjacent tissue, as well as hepatoma cell lines, in patients with hepatitis B-related hepatocellular carcinoma (HCC) , and the association between its expression level and clinicopathological featur...

Association between the expression of somatostatin receptors and pathological features, prognosis in hepatocellular carcinoma
Zhu Feng, Feng XiaoHai, An Yue
2018, 34(2): 314-320. DOI: 10.3969/j.issn.1001-5256.2018.02.019
Abstract:
Objective To investigate the expression of somatostatin receptors (SSTRs) in hepatocellular carcinoma (HCC) tissue and its association with clinicopathological features and prognosis of HCC.Methods HCC samples were collected from 80 patients who visited Third Hospital of PLA and Department of Hepato...
Inhibitory effect of fibroblast growth factor-21 on the carcinogenesis of L02 cells induced by diethylnitrosamine
Li ShuHuan, Han JiWu
2018, 34(2): 321-326. DOI: 10.3969/j.issn.1001-5256.2018.02.020
Abstract:

Objective To investigate the inhibitory effect of fibroblast growth factor-21 (FGF-21) on the carcinogenesis of L02 cells induced by diethylnitrosamine (DEN) .Methods L02 cells were cultured and treated with different concentrations of DEN (1, 10, 20, 50, 100, and 150 μmol/L) .MTT assay was used to ...

Original articles_Biliary diseases
Value of serum and biliary carcinoembryonic antigen, carbohydrate antigen 19-9, and carbohydrate antigen 24-2 in diagnosis of benign and malignant biliary obstructive diseases
Liu Tao, Luo YaoBing, Zhang JiaYao
2018, 34(2): 327-331. DOI: 10.3969/j.issn.1001-5256.2018.02.021
Abstract:

Objective To investigate the value of serum and biliary carcinoembryonic antigen (CEA) , carbohydrate antigen 19-9 (CA19-9) , and carbohydrate antigen 24-2 (CA24-2) in the diagnosis of benign and malignant biliary obstructive diseases.Methods A total of 40 patients with benign biliary obstructive di...

Clinical effect of laparoscopic cholecystectomy and prognostic analysis in patients with acute cholecystitis
Xi GuangLi, Dong Hao
2018, 34(2): 332-336. DOI: 10.3969/j.issn.1001-5256.2018.02.022
Abstract:

Objective To investigate the effect of laparoscopic cholecystectomy on intraoperative and postoperative recovery and changes in serum levels of lipopolysaccharide (LPS) , amylase (AMY) , and adrenocorticotropic hormone (ACTH) after surgery in patients with acute cholecystitis (AC) .Methods A total o...

Clinical effect of biliary metal stent implantation via endoscopic retrograde cholangiopancreatography in treatment of unresectable malignant extrahepatic biliary obstruction
Xu Gang
2018, 34(2): 337-340. DOI: 10.3969/j.issn.1001-5256.2018.02.023
Abstract:

Objective To investigate the clinical effect and safety of biliary metal stent implantation via endoscopic retrograde cholangiopancreatography (ERCP) in the treatment of malignant extrahepatic biliary obstruction.Methods A total of 40 patients with unresectable malignant extrahepatic biliary obstruc...

Efficacy and safety of minor endoscopic sphincterotomy combined with endoscopic papillary large balloon dilation in treatment of elderly patients with multiple large common bile duct stones
He YongFeng, Tang ShanHong, Guo WenWei, Xiao Xiang, Ma WeiPing, Zou Qiang, Liu Xiao, Guo LianBin, Yang XiaoCui
2018, 34(2): 341-345. DOI: 10.3969/j.issn.1001-5256.2018.02.024
Abstract:

Objective To investigate the clinical effect and safety of minor endoscopic sphincterotomy (m EST) combined with endoscopic papillary large balloon dilation (EPLBD) in the treatment of elderly patients with multiple large common bile duct stones.Methods A retrospective analysis was performed for 229...

Original articles_Pancreatic diseases
Predictive value of early measurement of serum procalcitonin and C-reactive protein for infectious pancreatic necrosis
Luo LiYa, Xiong Can, Chen XiaoQin
2018, 34(2): 346-349. DOI: 10.3969/j.issn.1001-5256.2018.02.025
Abstract:

Objective To investigate the predictive value of early measurement of serum inflammatory mediators for infectious pancreatic necrosis secondary to severe acute pancreatitis (SAP) .Methods A retrospective analysis was performed for the clinical data of 166 patients who were admitted to our hospital f...

Effect of interference of Sema4D expression on cell biological characteristics in pancreatic cancer
Hou LiYan, Jia RuJiang, Ren LiBing, Yang GengWu
2018, 34(2): 350-353. DOI: 10.3969/j.issn.1001-5256.2018.02.026
Abstract:

Objective To investigate the effect of interference of Sema4D expression on cell biological behavior in pancreatic cancer.Methods Sema4D-siRNA was designed, synthesized, and transfected into a human pancreatic cancer cell line.The cells were divided into siRNA transfection group, negative control gr...

Original articles_Others
Clinical features of drug-induced liver injury: an analysis of 445 cases
Zhu ChunWu, Wang HaiNan, Yuan JiLi, Peng Yuan, Zhang YaLei, Xue DongYing, Zhang Qin, Liu ChengHai
2018, 34(2): 354-358. DOI: 10.3969/j.issn.1001-5256.2018.02.027
Abstract:

Objective To investigate the clinical features of drug-induced liver injury (DILI) by descriptive analysis.Methods A retrospective analysis was performed for the clinical data of 445 patients who were diagnosed with DILI in Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese M...

Chlorogenic acid exerts preventive and therapeutic effects on nonalcoholic fatty liver disease by inhibiting the JNK signaling pathway
Yan Hua, Zhang Ying, Wang Huan, Gao YanQiong, Liu GuiSheng, Lei JianYuan
2018, 34(2): 359-363. DOI: 10.3969/j.issn.1001-5256.2018.02.028
Abstract:

Objective To investigate the role of chlorogenic acid (CG) in nonalcoholic fatty liver disease (NAFLD) and possible molecular basis, since NAFLD is closely associated with insulin resistance and CG can regulate glucose and lipid metabolism and improve insulin resistance.Methods A total of 30 Sprague...

Clinical features of patients with acute/subacute liver failure complicated by acute kidney injury
Chen Jing, Liu XiaoYan, Tong JingJing, Zhang LiNa, Guan ChongDan, Yan LiLong, Hu JinHua, Su HaiBin
2018, 34(2): 364-367. DOI: 10.3969/j.issn.1001-5256.2018.02.029
Abstract:

Objective To evaluate the clinical features of patients with acute/subacute liver failure (ALF/SALF) complicated by acute kidney failure (AKI) .Methods A retrospective analysis was performed for the clinical data of 115 ALF/SALF patients who were admitted to302 Hospital of PLA from January 2015 to D...

Effect of ulinastatin combined with ischemic preconditioning on hepatic ischemia-reperfusion injury in rats
Chen BaoHe, Li WenMei
2018, 34(2): 368-372. DOI: 10.3969/j.issn.1001-5256.2018.02.030
Abstract:

Objective To investigate the effect of ulinastatin (UTI) preconditioning combined with ischemic preconditioning (IPC) on hepatic ischemia-reperfusion (IR) injury in rats and possible mechanism of action.Methods A total of 50 male Sprague-Dawley rats were randomly divided into sham-operation group, I...

Establishment of animal model for Echinococcus inoculation infection in Microtus fuscus in Qinghai-Tibet Plateau
Wang Zhan, Xu Jin, Wang HaiJiu, Zhou Ying, Ren Li, Yang DanCaiRang, Hou LiChao, Fan HaiNing
2018, 34(2): 373-377. DOI: 10.3969/j.issn.1001-5256.2018.02.031
Abstract:

Objective To analyze whether Microtus fuscus in Qinghai-Tibet Plateau can be used as an animal model for Echinococcus infection.Methods Sixty wild voles (Microtus fuscus) were equally divided into groups A, B, and C to undergo Echinococcus inoculation through subcutaneous injection, direct transhepa...

Case reports
Prednisolone combined with hyperbaric oxygen used to control radiation-induced gastritis after radiotherapy for hepatocellular carcinoma: a case report
Zhang Ying, Ji HuiFan, Zhang ZeTian, Guo XiaoLin
2018, 34(2): 378-380. DOI: 10.3969/j.issn.1001-5256.2018.02.032
Abstract:
A case of primary hepatic lymphoma initially presenting as autoimmune hemolytic anemia
Wang Yan, Tang Yang, Guo XiaoLin, Yang Yan
2018, 34(2): 381-382. DOI: 10.3969/j.issn.1001-5256.2018.02.033
Abstract:
Colchicine-induced liver injury with autoimmune features: a case report
Chen XiaoQian, Zhang Feng, Wang ZhiYu, Cai YanJun, Qi Yue
2018, 34(2): 383-386. DOI: 10.3969/j.issn.1001-5256.2018.02.034
Abstract:
Adult-onset Still′s disease misdiagnosed as liver abscess: a case report and literature review
Kang LiMin, Zheng Yong
2018, 34(2): 387-388. DOI: 10.3969/j.issn.1001-5256.2018.02.035
Abstract:
Cyst of the gallbladder with retention liver cyst: a case report and literature review
Cao TongYu, Wang GuanXi, Cui HongYuan, Qiao JiangChun, Wei JunMin
2018, 34(2): 389-392. DOI: 10.3969/j.issn.1001-5256.2018.02.036
Abstract:
Ceftriaxone-induced gallstones: a case  report and literature review
Yao Wei, Wang EnCheng, Mi ShaoPing, Zhang GuangHai, Wang Jing
2018, 34(2): 393-395. DOI: 10.3969/j.issn.1001-5256.2018.02.037
Abstract:
Endoscopic retrograde cholangiopancreatography for treating common bile duct stones in patients with situs inversus totalis: a case report and literature review
Shi Wei, Sun RenHu, Han ShuTang, Wu DaPeng
2018, 34(2): 396-397. DOI: 10.3969/j.issn.1001-5256.2018.02.038
Abstract:
A case of common bile duct neurofibroma
Xuan ZhiLu, Liu Feng, Wu Bo, Liu SongYang, Han KaiZe, Liu YaHui
2018, 34(2): 398-399. DOI: 10.3969/j.issn.1001-5256.2018.02.039
Abstract:
Gallbladder neuroendocrine carcinoma: a report of 3 cases and literature review
Hao ZhiQiang, Li WenXin, Li Qiang, He ZhongYe, Shang Hai, Fu XiBo, Hua XiangDong
2018, 34(2): 400-402. DOI: 10.3969/j.issn.1001-5256.2018.02.040
Abstract:
Reviews
Change in immune status after antiviral therapy in patients with hepatitis C virus infection
Jiang YingYing, Zhang XiaoHui, Zheng SuJun
2018, 34(2): 403-406. DOI: 10.3969/j.issn.1001-5256.2018.02.041
Abstract:

Hepatitis C virus (HCV) infection is a global public health issue.At present, pegylated interferon (IFN) combined with ribavirin is the major therapeutic regimen for anti-HCV treatment in China, but this regimen cannot achieve ideal sustained virologic response.Direct-acting antivirals (DAA) have ac...

Association between hepatitis C virus infection and atherosclerosis
Zhao Jian, Wei Bo, Liang Chun
2018, 34(2): 407-409. DOI: 10.3969/j.issn.1001-5256.2018.02.042
Abstract:

Chronic infection and inflammation are associated with the development of atherosclerosis, and hepatitis C virus (HCV) infection is a relatively common infectious disease.This article reviews the latest advances in the association between HCV infection and atherosclerotic diseases.Studies have shown...

Association of direct-acting antiviral therapy for hepatitis C with the development and recurrence of liver cancer
Li Yan, Liu Lei, Luo ShuLan, Luo Chao, Tang ShanHong
2018, 34(2): 410-413. DOI: 10.3969/j.issn.1001-5256.2018.02.043
Abstract:

Chronic hepatitis caused by hepatitis C virus (HCV) infection is one of the leading causes of liver cirrhosis and hepatocellular carcinoma.In recent years, direct-acting antiviral agents (DAAs) have gradually become main drugs for the treatment of hepatitis C.Studies have shown that DAAs may increas...

Clinical effect of transcatheter arterial chemoembolization in treatment of primary liver cancer: application and research advances
Wang Hui, Pan YuGuo, Xia JinTang, Zhou MiMi, Cai Chun
2018, 34(2): 414-418. DOI: 10.3969/j.issn.1001-5256.2018.02.044
Abstract:

Primary liver cancer ranks fourth among the common malignant tumors in China and is the third leading cause of death.At present, only 20% patients with liver cancer are eligible for radical resection.Many clinical studies have confirmed that transcatheter arterial chemoembolization (TACE) has a good...

Research advances in secreted protein acidic and rich in cysteine in hepatocellular carcinoma
Feng Ying, Yang Xue, Wang XianBo
2018, 34(2): 419-423. DOI: 10.3969/j.issn.1001-5256.2018.02.045
Abstract:

Primary liver cancer is a common malignant tumor in clinical practice, and secreted protein acidic and rich in cysteine (SPARC) plays a very important role in the progression and metastasis of liver cancer.This article introduces the structure and biological function of SPARC and analyzes its mechan...

Recent advances in targeted drug therapy for hepatocellular carcinoma
Fan YongQiang, Dong ShengLi
2018, 34(2): 424-428. DOI: 10.3969/j.issn.1001-5256.2018.02.046
Abstract:

More and more clinical trials have proved the efficacy of targeted drugs in the treatment of hepatocellular carcinoma (HCC) .With the development of science and technology, more and more targeted drugs have appeared.In recent years, targeted drugs such as regorafenib and ramucirumab have shown great...

Association between estrogen receptor gene polymorphisms and the development and progression of hepatocellular carcinoma
Ran XiaoJuan, Yang Jing
2018, 34(2): 429-432. DOI: 10.3969/j.issn.1001-5256.2018.02.047
Abstract:

The development and progression of hepatocellular carcinoma (HCC) is associated with estrogen, which exerts its physiological effect by binding to estrogen receptor (ER) .The function of ER is regulated by related genes, while the expression and function of these genes are affected by gene polymorph...

Advances in the treatment of nonalcoholic fatty liver disease
Niu HaiYan, Li Hai, Ding YuPing
2018, 34(2): 433-437. DOI: 10.3969/j.issn.1001-5256.2018.02.048
Abstract:

The incidence rate of nonalcoholic fatty liver disease (NAFLD) has been increasing year by year in China, and NAFLD has become one of the common chronic diseases that affect the health of Chinese residents.This article introduces the role of lifestyle intervention, reviews the types of drugs used in...

Advances in the treatment of acute liver failure
Luo Ling, Zhang QiongFang, Zhang DaZhi
2018, 34(2): 438-443. DOI: 10.3969/j.issn.1001-5256.2018.02.049
Abstract:

Acute liver failure (ALF) is a rare life-threatening disease with rapid progression and a low survival rate and affects the function of multiple organ systems.Early identification of cause and protection of vital organs are critical for patients' survival.With the development in artificial liver, st...

Association between cholangiocarcinoma and Helicobacter pylori
Yuan Bo, Li JianGong, Cheng Yu
2018, 34(2): 444-447. DOI: 10.3969/j.issn.1001-5256.2018.02.050
Abstract:

Helicobacter pylori (HP) has been listed as the first carcinogen for gastric cancer by WHO.Recent studies have shown that HP infection is associated with a variety of tumors in other parts.This article introduces the current research on HP infection and intrahepatic/extrahepatic bile duct neoplasms ...